Mono Pharmacare P/B Ratio

Mono Pharmacare (MONOPHARMA) P/B ratio is 0.71 (Low), book value per share ₹17.22 vs Healthcare average P/B of -0.99 — Low - Trading below book value, may indicate undervaluation. For live price, earnings yield and the full fundamental profile, see MONOPHARMA stock overview.

Current P/B Ratio
0.71
Low Valuation
Low - Trading below book value, may indicate undervaluation

Current Valuation Metrics

P/B Ratio 0.71
Current Price
Book Value/Share ₹17.22
Exchange None

Book Value Breakdown (2025)

Balance Sheet Components
Total Equity ₹31 Cr
Share Capital ₹18 Cr
Reserves & Surplus ₹14 Cr
Outstanding Shares 18,000,000
Book Value per Share ₹17.22

Valuation Signal

Signal Undervalued

Sector Context

Sector Average -0.99
Sector Median 0.62
Sector Rank #11 of 50
Sector Percentile 22.0%

MONOPHARMA P/B Ratio — Valuation Insights & Book Value Analysis

Mono Pharmacare price-to-book ratio interpretation, valuation status and historical context — current P/B 0.71 (Low). Check Mono Pharmacare networth to track the company's total market size over time.

  • Stock appears undervalued with PB of 0.71, trading below book value
  • Trading below book value - potential value opportunity or financial distress signal
  • Trading at premium to sector average PB of -0.99

MONOPHARMA vs Healthcare Peers — P/B Ratio Comparison

Mono Pharmacare P/B 0.71 vs Healthcare average -0.99, median 0.62 — range -36.63–1.06.

Sector Average
-0.99
Sector Median
0.62
Lowest P/B
-36.63
Highest P/B
1.06
Companies
50
Company Symbol P/B Ratio Market Cap (₹ Cr) Valuation
Rekvina Laboratories VINRKLB -36.63 ₹28 Low
Sun Pharma Advanced Rese… SPARC -13.83 ₹4,744 Low
Span Divergent SDL -6.32 ₹19 Low
Oxygenta Pharmaceutical OXYGENTAPH -5.54 ₹203 Low
Satiate Agri SATAGRI -3.39 ₹8 Low
Adline Chem Lab ADLINE -3.03 ₹5 Low
Bharat Immunologicals BIBCL -2.35 ₹76 Low
Parmax Pharma PARMAX -2.09 ₹12 Low
Krebs Biochemicals & Ind… KREBSBIO -0.8 ₹128 Low
Cresanto Global CRESANTO -0.7 ₹2 Low